All tenders
75A50126C00005
THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TREAT PULMONARY FOAM THE INHALATION OF CHEMICAL AGENTS CAUSES.
Department of Health and Human Services · MN, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50126C00005
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TREAT PULMONARY FOAM THE INHALATION OF CHEMICAL AGENTS CAUSES.
- Source
- usaspending
- Source ID
- CONT_AWD_75A50126C00005_7505_-NONE-_-NONE-
Details
- Location
- MN, United States
Description
THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TREAT PULMONARY FOAM THE INHALATION OF CHEMICAL AGENTS CAUSES. Awarded to: ISOLA THERAPEUTICS INC Sub-agency: Office of Assistant Secretary for Preparedness and Response Contract type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/05/01 12:00:00 AM UTC
- Closing date
- 2028/10/31 12:00:00 AM UTC
Estimated value
$7.5M USD
Classification
Normalized category
Healthcare & Medical